The Know AML website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and Know AML cannot guarantee the accuracy of translated content. Know AML and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
What emerging dynamics could impact care in acute myeloid leukemia?
Gail Roboz
November 20, 2020
During Blood Cancer Awareness Month, Know AML spoke to Gail Roboz, a world-leading doctor in acute myeloid leukemia who is based at Weill Medical College, New York, U.S. We asked, "What emerging dynamics could impact care the most in acute myeloid leukemia in the next 5 years?" In this video, Gail describes the changes in treatment landscape for patients with acute myeloid leukemia with the recent advancement of novel therapies and treatment combinations, and especially the availability of oral agents.
To what extent do you agree with the following statements?
Please rate between 1 and 5, with 1 being 'strongly disagree' and 5 being 'strongly agree'.
